Menard Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,087
Closed -$307K 229
2024
Q4
$307K Buy
3,087
+218
+8% +$22.5K 0.18% 93
2024
Q3
$326K Buy
2,869
+70
+3% +$8.32K 0.21% 94
2024
Q2
$347K Buy
2,799
+8
+0.3% +$1.03K 0.25% 89
2024
Q1
$368K Buy
2,791
+113
+4% +$13.9K 0.31% 80
2023
Q4
$292K Sell
2,678
-77
-3% -$7.99K 0.36% 59
2023
Q3
$284K Buy
2,755
+364
+15% +$39.2K 0.41% 56
2023
Q2
$276K Buy
2,391
+319
+15% +$36.2K 0.57% 42
2023
Q1
$220K Buy
2,072
+7
+0.3% +$756 0.51% 58
2022
Q4
$229K Sell
2,065
-903
-30% -$92.3K 0.55% 60
2022
Q3
$256K Sell
2,968
-690
-19% -$61.6K 0.46% 63
2022
Q2
$333K Buy
+3,658
New +$324K 0.55% 60
2020
Q4
Sell
-3,923
Closed -$310K 152
2020
Q3
$310K Sell
3,923
-144
-4% -$11.3K 0.36% 75
2020
Q2
$300K Buy
+4,067
New +$306K 0.38% 65
2020
Q1
Sell
-7,240
Closed -$628K 86
2019
Q4
$628K Buy
+7,240
New +$595K 0.6% 51

Other funds holding MRK

Menard Financial Group's MRK Position: Q1 2025 in Review

Menard Financial Group sold out of Merck (MRK) in Q1 2025, closing a stake of 3,087 shares — an estimated $307K sold.

Menard Financial Group first reported a position in MRK in Q4 2019 and held it in 14 quarters. The position peaked at $628K in Q4 2019. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Menard Financial Group reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 3,087 Merck shares in Q1 2025, an estimated $307K.
  • Menard Financial Group first reported a position in Merck in Q4 2019 and held it in 14 quarters.
  • Menard Financial Group's Merck position peaked at $628K in Q4 2019.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.